Cardioprotective effects of a novel designer C-type natriuretic peptide-based therapeutic, C53 , for the prevention of post-myocardial infarction heart failure
Event:
ESC Congress 2018
Topic:
Pharmacotherapy
Session:
Targeting reverse remodelling in heart failure
